4-(1H-Benzo[d]imidazol-2-yl)aniline

Catalog No.: 
ACJTNB968
CAS No.: 
2963-77-1
Molecular Formula: 
C13H11N3
Molecular Weight: 
209.25
4-(1H-Benzo[d]imidazol-2-yl)aniline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$146.00In stockIn stock
25g95%$708.00InquiryInquiry
100g95%$2359.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(1H-Benzo[d]imidazol-2-yl)aniline
IUPAC Name4-(1H-benzo[d]imidazol-2-yl)aniline
MDL No.MFCD00454395
Molecular FormulaC13H11N3
Molecular Weight209.25
SMILESNC1=CC=C(C2=NC3=CC=CC=C3N2)C=C1
InChI KeyVQFBXSRZSUJGOF-UHFFFAOYSA-N
Synonym2-(4-aminophenyl)benzimidazole | 2-(4-aminophenyl)-benzimidazole | DTXSID10323237 | 4-(1h-benzimidazol-2-yl) phenylamine | AKOS000120493 | BRD-K95559356-001-01-4 | SMR000015520 | TimTec1_000998 | 2-[p-Aminophenyl]benzimidazole | SY079091 | 4-(1H-benzoimid
CAS No.2963-77-1
PubChem CID345677

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H319
Precautionary Statement(s)
P305+P351+P338

Synthetic Route by SureRoute

1. ACJTNB968 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNFPB351 route compound structure diagram
    ACNFPB351138-84-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJTNB968 route product structure diagram
    ACJTNB9682963-77-1In Stock
Inquiry

2. ACJTNB968 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMPIV920 route compound structure diagram
    ACMPIV920729-13-5In Stock
  2. Then
  3. ACJTNB968 route product structure diagram
    ACJTNB9682963-77-1In Stock
Inquiry

3. ACJTNB968 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJTNB968 route product structure diagram
    ACJTNB9682963-77-1In Stock
Inquiry

Comments (0)